A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Astellas Pharma Inc
Astellas Pharma Inc
University College, London
National Institutes of Health Clinical Center (CC)
Maia Biotechnology
Eli Lilly and Company
Astellas Pharma Inc
Institut Claudius Regaud
Société Algérienne de Formation et Recherche en Oncologie
M.D. Anderson Cancer Center
Astellas Pharma Inc
BigHat Biosciences, Inc.
Canadian Cancer Trials Group
EMD Serono
Janssen Research & Development, LLC
Genentech, Inc.
Plexium, Inc.
AstraZeneca
Acerand Therapeutics Limited
National Institutes of Health Clinical Center (CC)
Lithuanian University of Health Sciences
The First Affiliated Hospital of Zhengzhou University
University Health Network, Toronto
Lumos Pharma
Turning Point Therapeutics, Inc.
Asan Medical Center
Bristol-Myers Squibb
Astellas Pharma Inc
Fudan University
AstraZeneca
Boston Scientific Corporation
Corcept Therapeutics
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Centre Hospitalier Departemental Vendee
Rutgers, The State University of New Jersey
Rondo Therapeutics
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Candel Therapeutics, Inc.
Case Comprehensive Cancer Center
University Hospital, Toulouse
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Centre Oscar Lambret
Centre Oscar Lambret
Eisai Inc.
Astellas Pharma Inc
CancerCare Manitoba
Brigham and Women's Hospital
The Methodist Hospital Research Institute
University Hospital, Antwerp